» Articles » PMID: 27110940

Mechanism and Therapy of Brain Edema After Intracerebral Hemorrhage

Overview
Journal Cerebrovasc Dis
Publisher Karger
Date 2016 Apr 26
PMID 27110940
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intracerebral hemorrhage (ICH) is a subtype of stroke with a severe high mortality and disability rate and accounts for about 10-15% of all strokes. The oppression and destruction by hematoma to brain tissue cause the primary brain injury. The inflammation and coagulation response after ICH would accelerate the formation of brain edema around hematoma, resulting in a more severe and durable injury. Currently, treatments for ICH are focusing on the primary injury including reducing intracranial hypertension, blood pressure control, and rehabilitation. There is a short-of-effective medical treatment for secondary inflammation and reducing brain edema in ICH patients. So, it is very important to study on the relationship between brain edema and ICH.

Summary: Many molecular and cellular mechanisms contribute to the formation and progress of brain edema after ICH; inhibition of brain edema provides favorable outcome of ICH.

Key Messages: This review mainly discusses the pathology and mechanism of brain edema, the effects of brain edema on ICH, and the methods of treating brain edema after ICH.

Citing Articles

Exogenous mitochondria added on benefits for cellular prion protein overexpression in adipose-derived mesenchymal stem cells treatment on intracranial hemorrhage rat.

Lin K, Yeh J, Sung P, Yin T, Chiang J, Huang C J Mol Histol. 2025; 56(2):106.

PMID: 40080193 PMC: 11906555. DOI: 10.1007/s10735-025-10382-x.


The Triad of Blood-Brain Barrier Integrity: Endothelial Cells, Astrocytes, and Pericytes in Perinatal Stroke Pathophysiology.

Garcia-Martinez T, Gornatti D, Ortiz M, Canellas G, Heine-Suner D, Vives-Bauza C Int J Mol Sci. 2025; 26(5).

PMID: 40076511 PMC: 11900453. DOI: 10.3390/ijms26051886.


Effect of adjuvant cisternostomy on the prognosis of patients with severe traumatic brain injury: A single center's retrospective study.

Chen P, Zheng W, Wang W, Shu D, Xu D, Zhang Q Medicine (Baltimore). 2025; 104(10):e41699.

PMID: 40068086 PMC: 11902972. DOI: 10.1097/MD.0000000000041699.


TRIOL attenuates intracerebral hemorrhage injury by bidirectionally modulating microglia- and neuron-mediated hematoma clearance.

Wei C, Chen C, Li S, Ding Y, Zhou Y, Mai F Redox Biol. 2025; 80:103487.

PMID: 39756315 PMC: 11758845. DOI: 10.1016/j.redox.2024.103487.


Exogenous ketone therapy does not protect brain tissue after moderate-sized intracerebral hemorrhage despite signs of early neurological benefit.

Sander N, Soni S, Wilkinson C, Khiabani E, Dyck J, Colbourne F PLoS One. 2024; 19(12):e0311778.

PMID: 39636949 PMC: 11620376. DOI: 10.1371/journal.pone.0311778.